By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Purpose The purpose of this study was to utilize proprietary dissolution technologies (SDi2) to investigate the effect of formulation differences on drug release for immediate (IR) and extended (ER) release Metformin tablets.